Long-term outcomes in elderly patients (pts) from IMvigor210: Atezolizumab (atezo) in metastatic urothelial cancer (mUC) Meeting Abstract


Authors: Balar, A. V.; Dreicer, R.; Loriot, Y.; Perez-Gracia, J. L.; Hoffman-Censits, J. H.; Petrylak, D. P.; Van Der Heijden, M. S.; Shen, X.; Ding, B.; Ramirez-Montagut, T.; Rosenberg, J. E.
Abstract Title: Long-term outcomes in elderly patients (pts) from IMvigor210: Atezolizumab (atezo) in metastatic urothelial cancer (mUC)
Meeting Title: 2019 Genitourinary Cancers Symposium
Journal Title: Journal of Clinical Oncology
Volume: 37
Issue: 7 Suppl.
Meeting Dates: 2019 Feb 14-16
Meeting Location: San Francisco, CA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2019-03-01
Language: English
ACCESSION: WOS:000489108800410
DOI: 10.1200/JCO.2019.37.7_suppl.394
PROVIDER: wos
Notes: Meeting Abstract: 394 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jonathan Eric Rosenberg
    510 Rosenberg